Atlas Trials

A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia

Clinical trial NCT06714461 · COMPLETED

Trial details

NCT number
NCT06714461
Sponsor
Sanofi
Status
COMPLETED
Study type
OBSERVATIONAL
Rheumatoid ArthritisPsoriatic Arthritis
Start date
2025-05-05
Primary completion
2026-05-14
Enrollment
302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.